Mutations in bone morphogenetic protein receptor 2 (BMPR2) are found in approximately 80% of individuals with hereditary PAH (∼6% of PAH cases), and in up to 20% of individuals with idiopathic disease. Disease penetrance in carriers is estimated at 20%, meaning that a range of additional ...